API Laboratory & Production Data Integrity (DI) Compliance Controls
Introducing data integrity matching the FDA ALCOA+ framework, focusing on chromatography software audit trails, e-signatures, and batch record controls.
Data Integrity (DI) is a critical compliance checkpoint during FDA, EMA, and WHO site audits. The baseline logic is the ALCOA+ framework (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available). Technologically, this involves Computerized System Validation (CSV, per GAMP 5), restricting software admin access (analysts must not have admin rights), and keeping chromatographic audit trails enabled with secondary reviews.
Three Critical DI Deficiencies in FDA Audits
Data integrity issues trigger inspection failures and Warning Letters. Facilities must restrict system access rights to eliminate the following vulnerabilities.
- Testing to Compliance: running "informal test injections" or deleting failing chromatograms from database records
- Shared Accounts: analysts sharing a single login credential, making experimental steps unattributable
- Backdating: filling batch records retrospectively rather than contemporaneously at the time of operation
FAQ
Can analysts delete chromatogram data in Empower?+
Absolutely not. All raw chromatographic data must be retained in the system database. Any deletion of data will be flagged by regulators as suspected data manipulation. The correct way is to log a deviation, investigate the anomaly, and keep all files for evaluation.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
